Disclosure Of First-Time Adoption [Text Block]

Biocartis Group NV - Filing #3123162

Concept	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	526,405 EUR	5,572 EUR	—	—	33,897 EUR	33,897 EUR	711,874 EUR	6,862 EUR	220,657 EUR	—	—	—	455,343 EUR	36,824 EUR	220,657 EUR	—	5,153 EUR	711,874 EUR	6,102 EUR	—	36,824 EUR	—	84,480 EUR	5,291 EUR	84,480 EUR	698,027 EUR	392,259 EUR	4,670 EUR	220,668 EUR
Comprehensive income	—	—	419,000 EUR	71,481 EUR	—	—	—	—	—	71,481 EUR	71,062 EUR	62,945 EUR	—	—	—	63,084 EUR	—	—	—	139,000 EUR	—	62,945 EUR	—	—	—	—	—	—	—
Profit (loss)	—	—	—	71,472 EUR	—	—	—	—	—	71,472 EUR	71,472 EUR	62,934 EUR	—	—	—	62,934 EUR	—	—	—	—	—	62,934 EUR	—	—	—	—	—	—	—